Skip to main content
. 2021 Dec 31;26(4):227–236. doi: 10.6065/apem.2142164.082

Table 1.

anorexigenic or adipose-derives hormones in Prader-Willi syndrome (PWS)

Hormone Site of production Site of action Physiological role Patients with PWS References
Obestatin Stomach, derived from preproghrelin AgRP in arcuate nucleus Appetite ↓ Contradictory results [43,45,48]
Gastric emptying↓ Higher in young (<3 yr) PWS infants
Body weight ↓ No difference between obese PWS and obese control
Adiponectin Adipose tissue β-cell in pancreas Insulin sensitivity ↑ Higher in PWS than obese control [42,44,46]
Modulate appetite and energy homeostasis
Pancreatic polypeptide (PP) PP cell in pancreas Y4 receptors in hypothalamic feeding nuclei Appetite ↓ Similar or lower in PWS than control [47]
Regulate pancreatic secretion Decreased postprandial level in PWS
Peptide YY Gastrointestinal tract NPY receptor Appetite ↓ Contradictory results [41,47]
Gastric motility ↓
Pancreatic secretion ↓
Adropin Liver, brain Multiorgan Insulin sensitivity ↑ Higher in PWS children [48]
Body weight, fat mass ↓
Glucagon like peptide-1 Intestine Pancreas Insulin sensitivity ↑ No difference between PWS and control [46]
Satiety ↑
Leptin Adipose tissue POMC and NPY in arcuate nucleus Satiety ↑ No difference between obese PWS and obese control [46,47,49]

AgRP, agouti-related peptide; NPY, neuropeptide Y; POMC, proopiomelanocortin.